Remove Biopharma Remove Competition Remove Prospecting Remove Training
article thumbnail

HCP Engagement & Education

PM360

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.

article thumbnail

Small and medium biotechs jump on obesity train

Pharmaceutical Technology

This year, competition in the obesity therapeutic landscape has ramped up as biotechs aim to follow the success of blockbuster drugs from Novo Nordisk , Eli Lilly and more. In the panel, Melanie Senior, a biopharma reporter at Nature Biotech also pointed out reimbursement issues for obesity drugs.